Overview
Perinatal subependymal hemorrhage, often categorized as periventricular-intraventricular hemorrhage (PIVH), is a common complication in very preterm infants, significantly impacting neurodevelopmental outcomes. 1Diagnosis
Key Diagnostic Criteria: Identified through neuroimaging (ultrasound, MRI) in neonates with gestational age <32 weeks.
Grading System: PIVH is graded from I to IV based on severity and extent of bleeding.
Recommended Tests: Serial cranial ultrasounds are essential for early detection and monitoring progression. 1Management
First-Line Treatments: No specific pharmacological treatments are universally recommended; management focuses on supportive care including mechanical ventilation, fluid management, and prevention of secondary complications.
Adjunctive Measures: Targeted temperature management and prevention of anemia may indirectly support outcomes. 1Special Populations
Pediatrics: Very preterm infants (gestational age <32 weeks) are at highest risk. 1Key Recommendations
Infants with PIVH, particularly grades III and IV, have significantly higher rates of neurodevelopmental handicaps compared to those without hemorrhage (OR 3.0, CI [1.6, 5.5], p < 0.01) (Evidence: Moderate) 1
Grade I and II PIVH also correlate with increased risk of neurodevelopmental impairment (OR 2.1, CI [1.3, 3.3], p < 0.01), warranting close follow-up (Evidence: Moderate) 1
Serial cranial ultrasounds are crucial for monitoring PIVH progression and guiding clinical management (Evidence: Expert opinion) 1References
1 van de Bor M, Verloove-Vanhorick SP, Baerts W, Brand R, Ruys JH. Outcome of periventricular-intraventricular hemorrhage at 2 years of age in 484 very preterm infants admitted to 6 neonatal intensive care units in The Netherlands. Neuropediatrics 1988. link